Some experts say we’re in “the golden age of biotechnology.” Scientific advances are opening up possibilities for the treatment and prevention of diseases that could only have been imagined in the past. This golden age is also presenting tremendous opportunities for investors.
Biotech stocks offer the potential for substantial long-term returns. The best biotech stocks to buy right now boast strong pipelines, and some already have winning drugs on the market. Our pick for the day ticks all of these boxes.
Behind the Markets:
Our #1 Small-Cap Stock for October
Ex-Wall Street CEO Dylan Jovine is one of the best Small-Cap investors on earth.
He’s delivered 435% profits on ChemoCentrix, 220% returns on Editas, 159% profits with Magnolia Gas and 194% with Scotts Miracle Gro.
[Get his #1 Small-Cap for October here >>>>>>]
Vertex Pharmaceuticals (VRTX) is the undisputed leader in cystic fibrosis therapies. The company’s portfolio of approved CF drugs will deliver at least an estimated $8.4 billion this year, made possible by intense market penetration and decades-long devotion to research and development in the space.
So far, the company has remained enormously profitable and has continued expanding revenue within the CF market. Suppose management’s plans for expanded approvals for younger cohorts continue to come to fruition over the next few years. In that case, Vertex will eventually treat as many as 90% of all people with CF.
The company is moving its pipeline beyond CF with a handful of mid-stage clinical programs for pain relief, kidney disease, and genetic hematologic disorders like sickle cell disease. In other words, even if it eventually corners the entire CF therapies market, there will still be other growth opportunities.
You might also like:
- China to attack the Dollar on Jan. 6?
- Federal Reserve predicts 24,290% from here
- Buy this AI Stock before January 1
- Congress Just Fast-tracked New A.I. Energy Breakthrough
- Elon Musk: THIS will be bigger than Tesla
- The Cold, Hard Truth About A.I. Stocks
- EV charging stations that pay you up to $93/day!
- Legendary Wall Street Stock-Picker Names #1 A.I. Stock of 2023, Live On-Camera
- Missed NVIDIA? Don’t Miss This ‘Great $2 AI Moonshot’ Opportunity
- No 1 Stock to Buy ASAP